32 Results for "

quinazoline derivatives

" in MedChemExpress (MCE) Product Catalog:
Products (32)

32 Results for "quinazoline derivatives" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-B0371F
CAS No.: 63074-08-8
Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-B0371
CAS No.: 63590-64-7
Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-B0371A
CAS No.: 70024-40-7
Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride dihydrate works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride dihydrate has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0098
CAS No.: 74191-85-8
Synonyms: UK 33274
Doxazosin (UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0098A
CAS No.: 77883-43-3
Synonyms: UK 33274 mesylate
Doxazosin mesylate (UK 33274 mesylate) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107364
CAS No.: 1952236-05-3
Purity:  99.81%
Synonyms: Mol 211
Target:  

EGFR PI3K

Research Areas:  

Cancer

MTX-211 (Mol 211) is a dual inhibitor of EGFR and PI3K with IC50 values of <100 nM. MTX-211 can be used for the research of cancer and other diseases .
loading...
    loading...
Cat. No.: HY-Y0260
CAS No.: 13790-39-1
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

4-Chloro-6,7-dimethoxyquinazoline is a quinazoline derivative. 4-Chloro-6,7-dimethoxyquinazoline exhibits a significant interaction with the AChE protein (as demonstrated by molecular docking analysis). 4-Chloro-6,7-dimethoxyquinazoline is applicable to research related to Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-W012071
CAS No.: 16652-71-4
Research Areas:  

Others

(S)-Benzyl pyrrolidine-2-carboxylate hydrochloride is an intermediate in the synthesis of L-proline derivative peptides. (S)-Benzyl pyrrolidine-2-carboxylate hydrochloride is a key raw material for the synthesis of apoptosis inhibitor protein (IAP) antagonists and SMAC mimic tripeptide fragments (Boc-MeAla-Tle-Pro-OH). (S)-Benzyl pyrrolidine-2-carboxylate hydrochloride can be used to synthesize divalent quinazoline IAP antagonists .
loading...
    loading...
Cat. No.: HY-B0371S
CAS No.: 1006718-20-2
Terazosin-d8 is deuterium labeled Terazosin. Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...
Cat. No.: HY-101931
CAS No.: 1637443-98-1
Purity:  99.26%
Target:  

VEGFR

Research Areas:  

Cancer

hVEGF-IN-1, a quinazoline derivative, could specifically bind to the G-rich sequence in the internal ribosome entry site A (IRES-A) and destabilize the G-quadruplex structure. hVEGF-IN-1 binds to the IRES-A (WT) with a Kd of 0.928 μM in SPR experiments. hVEGF-IN-1 could hinder tumor cells migration and repress tumor growth by decreasing VEGF-A protein expression .
loading...
    loading...
Cat. No.: HY-178054
CAS No.: 2760446-25-9
Research Areas:  

Neurological Disease

LMDP10 is an orally active 3-amino quinazoline derivative with Keap1-Nrf2 pathway activation activity. LMDP10 binds to Keap1 to inhibit Keap1-Nrf2 interaction, thereby activating the Nrf2 pathway. LMDP10 elevates Nrf2, SOD, and GSH levels, reduces MDA and TNF-α levels, attenuates neurodegeneration, and improves memory function in Alzheimer’s disease (AD) rats. LMDP10 can be used for the study of AD .
loading...
    loading...
Cat. No.: HY-W010778
CAS No.: 231278-20-9
Target:  

Drug Derivative

Research Areas:  

Others

N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-iodo-quinazolin-4-amine is a quinazoline derivative that has also been used in the design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
loading...
    loading...
Cat. No.: HY-156287
CAS No.: 796079-91-9
Purity:  ≥97.0%
Target:  

Glycosidase

Research Areas:  

Cancer

GCase modulator-1 (compound 9g), a derivative of Quinazoline, is a modulator of GCase (Glucosidase) (AC50=2.23 μM) .
loading...
    loading...
Cat. No.: HY-19291
CAS No.: 149847-79-0
DL-017 is a Quinazoline derivative. DL-017 shows inhibitory constants of approximately 0.90 nM for α1-adrenergic receptors and 404 nM for Na + channels. DL-017 exerts antihypertensive effect .
loading...
    loading...
Cat. No.: HY-129427
CAS No.: 149847-87-0
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

DC-015 is a selective and orally active alpha 1-adrenoceptor antagonist on plasma lipid and vascular reactivity in hyperlipidaemic rodent model. DC-015 is a synthesized quinazoline derivative. DC-015 decreases mean arterial pressure in rats. DC-015 has antihypertensive activity .
loading...
    loading...
Cat. No.: HY-106554
CAS No.: 35795-16-5
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

Trimazosin is an orally active, quinazoline derivative which is structurally related to prazosin. Trimazosin shows hypotensive effect by selectively block α1-adrenoceptors .
loading...
    loading...
Cat. No.: HY-163421
CAS No.: 2414055-95-9
Target:  

Potassium Channel

Research Areas:  

Cancer

hERG-IN-2 (Compound 1) is a potent hERG inhibitor, with an IC50 of < 2 μM. hERG-IN-2 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-B0098S
CAS No.: 1126848-44-9
Synonyms: UK 33274-d8
Doxazosin-d8 is a deuterium labeled Doxazosin (UK 33274). Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic α1 adrenergic receptors .
loading...
    loading...
Cat. No.: HY-131449
CAS No.: 1486464-41-8
Target:  

Adrenergic Receptor

Research Areas:  

Others

Terazosin dimer impurity dihydrochloride, a dimer of Terazosin, is an impurity of Terazosin. Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist .
loading...
    loading...
Cat. No.: HY-106554A
CAS No.: 53746-46-6
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

Trimazosin hydrochloride hydrate is an orally active, quinazoline derivative which is structurally related to prazosin. Trimazosin shows hypotensive effect by selectively block α1-adrenergic receptor .
loading...
    loading...